SecBot SecBot
8-K ·Filed Oct 1, 2026

LFWD

Lifeward Ltd.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001178913-26-004685
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor the November 1, 2026 effective date for new CFO Rami Aviram's appointment. No immediate trading catalyst from this filing.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$5.96
T+0 close · Oct 1, 2026 · via day close
Latest settled
−0.84%
T+20 · $5.91 · next T+60 in 8w
vs SPY
−1.54%
α at T+20
Latest observation
+5.68%
T+22 · FF3 residual α
  1. T+0 · Oct 1 $5.96entry
  2. T+1 · 5w ago −1.85%α −2.59% · $5.85
  3. T+5 · 28d ago +7.89%α +6.58% · $6.43
  4. T+20 · 7d ago −0.84%α −1.54% · $5.91
  5. T+24 · todayOpen
  6. T+60 · in 8w Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lifeward Ltd. filed an 8-K confirming that CFO Almog Adar's departure became effective September 30, 2026. Interim CEO Josh Hexter has been designated as interim principal financial and accounting officer until November 1, 2026, when the previously announced new CFO Rami Aviram takes over. This is a routine administrative step in a pre-announced CFO transition with no new compensation or material changes.

Key Facts

  • CFO Almog Adar's departure effective September 30, 2026, as previously disclosed on August 31, 2026.
  • Interim CEO Josh Hexter designated as interim principal financial and accounting officer effective October 1, 2026.
  • Hexter will serve until November 1, 2026, when Rami Aviram becomes CFO as previously disclosed.
  • Hexter receives no additional compensation for the interim CFO role.

Financial Impact

No financial impact, administrative designation with no compensation change.

Risk Factors

  • No risks identified, this is a routine interim designation in a pre-announced transition.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001178913-26-004685
Document: 0001178913-26-004685-index-headers.html0001178913-26-004685
Document: 0001178913-26-004685-index.html0001178913-26-004685
Document: 0001178913-26-004685.txt0001178913-26-004685
23 reports for LFWD
Performance horizon
88% Hit rate @ T+5 7 of 8 bullish or bearish reports Went positive at some point 8 of 8 best @ T+60▲ +19.89%Aug 11, 2026
Filters
Rows
Reports for LFWD, sortable and filterable
TypeNow
Nov 3, 2026
1d ago
3
NEUTRAL ★ 2/10
$6.02awaiting T+5awaiting T+5$5.83 (−3.16%)
Oct 27, 2026
8d ago
8-K
NEUTRAL ★ 2/10
$6.04 $5.83▼ −3.48%▼ −1.49%$5.83 (−3.48%)
Oct 8, 2026
27d ago
8-K
BEARISH ★ 5/10
$6.49 $6.00▲ +7.55%▲ +5.58%$5.83 (+10.17%)
Oct 1, 2026
4w ago
8-K
NEUTRAL ★ 2/10
$5.96 $6.43▲ +7.89%▲ +6.58%$5.83 (−2.18%)
Sep 25, 2026
5w ago
DEF 14A
BEARISH ★ 7/10
$6.92 $6.67▲ +3.61%▲ +4.82%$5.83 (+15.75%)
Aug 14, 2026
11w ago
8-K
MIXED ★ 6/10
No priceawaiting T+5awaiting T+5No price
Aug 14, 2026
11w ago
Press Release
BEARISH ★ 6/10
$7.45 $7.32▲ +1.75%▲ +0.38%$5.83 (+21.74%)
Aug 11, 2026
12w ago
EFFECT
BEARISH ★ 7/10
$7.57 $7.41▲ +2.08%▲ +1.67%$5.83 (+22.93%)
Aug 7, 2026
12w ago
Press Release
NEUTRAL ★ 1/10
$7.69 $7.45▼ −3.06%▼ −3.46%$5.83 (−24.14%)
May 19, 2026
24w ago
8-K
NEUTRAL ★ 2/10
$6.40 $7.12▲ +11.17%▲ +8.93%$5.83 (−8.91%)
Showing 10 of 23

US Market Status

Market Closed · Opens Fri (13h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 1, 2026